Search
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Evan Foster advises clients on legal issues involving technology, data privacy and cybersecurity. Customers and vendors in the health care, life sciences, financial and manufacturing industries, among others, seek his advice on technology transactions and systems acquisition including matters...
Domingos Silva is co-chair of the firm's Intellectual Property Practice with extensive experience in the pharmaceutical, chemical, biotechnology, diagnostics, biochemistry, and materials science areas. Domingos has a Ph.D. in Organic Chemistry from Princeton University and conducted his post...
Brian Landry draws on a broad base of intellectual property experience involving patents, designs, trademarks, and copyrights and technical expertise to help clients identify, protect, and enforce their intellectual property. Brian has significant experience in the medical devices field as well as...
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...
Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...
A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...